These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21113656)

  • 1. Acquisition of metastatic tissue from patients with bone metastases from breast cancer.
    Hilton JF; Amir E; Hopkins S; Nabavi M; DiPrimio G; Sheikh A; Done SJ; Gianfelice D; Kanji F; Dent S; Barth D; Bouganim N; Al-Najjar A; Clemons M
    Breast Cancer Res Treat; 2011 Oct; 129(3):761-5. PubMed ID: 21113656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer.
    Aurilio G; Monfardini L; Rizzo S; Sciandivasci A; Preda L; Bagnardi V; Disalvatore D; Pruneri G; Munzone E; Della Vigna P; Renne G; Bellomi M; Curigliano G; Goldhirsch A; Nolè F
    Acta Oncol; 2013 Nov; 52(8):1649-56. PubMed ID: 23327413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.
    Amir E; Clemons M; Purdie CA; Miller N; Quinlan P; Geddie W; Coleman RE; Freedman OC; Jordan LB; Thompson AM
    Cancer Treat Rev; 2012 Oct; 38(6):708-14. PubMed ID: 22178456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous CT guided bone biopsy in patients with suspected bone neoplasm].
    Yasui K; Kanazawa S; Tanaka A; Hiraki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Mar; 56(4):178-82. PubMed ID: 8992453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
    Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ
    Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
    Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.
    Guarneri V; Giovannelli S; Ficarra G; Bettelli S; Maiorana A; Piacentini F; Barbieri E; Dieci MV; D'Amico R; Jovic G; Conte P
    Oncologist; 2008 Aug; 13(8):838-44. PubMed ID: 18650259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discordance between primary breast cancer and bone or bone marrow metastases.
    Yuda S; Shimizu C; Yoshida M; Shiino S; Kinoshita T; Maeshima AM; Tamura K
    Jpn J Clin Oncol; 2019 May; 49(5):426-430. PubMed ID: 30793198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant expression of hormone receptors and HER2 in breast cancer. A retrospective comparison of primary tumors with paired metachronous recurrences or metastases.
    Arapantoni-Dadioti P; Valavanis C; Gavressea T; Tzaida O; Trihia H; Lekka I
    J BUON; 2012; 17(2):277-83. PubMed ID: 22740206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R; Stevens J; McKinney C; Ibrahim NB
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer.
    Brown RS; Dogan A; Ell PJ; Payne HA; Masters JR; Harland SJ
    Prostate Cancer Prostatic Dis; 2002; 5(2):144-51. PubMed ID: 12497005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided needle biopsy for musculoskeletal lesions.
    Tsukushi S; Nishida Y; Yamada Y; Yoshida M; Ishiguro N
    Arch Orthop Trauma Surg; 2010 May; 130(5):699-703. PubMed ID: 20033699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discordance of estrogen receptor (ER), progestin receptor (PR), and HER-2 receptor statuses between primary and metastatic focuses of breast cancer].
    Wang B; Guan ZZ; Liu DG; Lin TY; Zhang L; Xia ZJ; Teng XY
    Ai Zheng; 2004 Dec; 23(12):1710-3. PubMed ID: 15601567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic role of fine-needle aspiration of bone lesions in patients with a previous history of malignancy.
    Treaba D; Assad L; Govil H; Sariya D; Reddy VB; Kluskens L; Green L; Selvaggi SM; Gattuso P
    Diagn Cytopathol; 2002 Jun; 26(6):380-3. PubMed ID: 12112828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.